One Health Approach to Antimicrobial Stewardship in Companion Animals – Tufts Vet School’s Claire Fellman, D.V.M., Ph.D., DACVIM (SA), DACVCP
Tufts University Cummings School of Veterinary Medicine’s Claire Fellman, D.V.M., Ph.D., DACVIM (SA), DACVCP is interested in One Health approaches to antimicrobial stewardship in veterinary medicine.
One Health interprofessional stewardship to combat antimicrobial resistance
Nature Medicine; January 19, 2023
Impact of antimicrobial use in dogs on antimicrobial resistance and shared flora with human owners
Antimicrob Steward Healthc Epidemiol; January 9, 2023
Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized Trial
Clin. Infect. Dis; January 6, 2023
Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis
Front Cell Infect Microbiol; January 6, 2023 (eCollection 2022)
Advances in the design of combination therapies for the treatment of tuberculosis
Expert Opin. Drug Discov.; December 28, 2022 (Online ahead of print)
The Challenge of Antibiotics Stewardship in Low Income Countries: The Case of the Democratic Republic of Congo – Tufts Vet’s Diafuka Saila-Ngita, DVM, MSc, PhD
Tufts University Cummings School of Veterinary Medicine’s Diafuka Saila-Ngita, DVM, MSc, PhD, is interested in addressing the challenges of antimicrobial stewardship in low-income nations such as the Democratic Republic of Congo.
Irene Nagawa, Inaugural Recipient of the Levy CIMAR’s Undergraduate Summer Internship
Senior at UMass Boston majoring in biology and working with the Levy CIMAR’s Aimee Shen, PhD; Inaugural recipient of the Levy CIMAR Undergraduate Summer Internship for Underrepresented Groups in Science and Medicine
Tuberculosis treatment failure associated with evolution of antibiotic resilience
Science; December 9, 2022
Developing a Mycobacterial Research Agenda – Tufts Medical Center’s Husain Poonawala, MBBS, MPH
Tufts Medical Center’s Husain Poonawala, MBBS, MPH, is interested in tuberculosis and non-tuberculous mycobacteria, how next-generation sequencing and novel diagnostic methods can be integrated into clinical care.